000 | 01278 a2200349 4500 | ||
---|---|---|---|
005 | 20250517035206.0 | ||
264 | 0 | _c20160509 | |
008 | 201605s 0 0 eng d | ||
022 | _a1998-3751 | ||
024 | 7 |
_a10.4103/0253-7613.157134 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSawant, Neena S | |
245 | 0 | 0 |
_aNeuroleptic malignant syndrome in cycloserine-induced psychosis. _h[electronic resource] |
260 |
_bIndian journal of pharmacology _c |
||
300 |
_a328-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibiotics, Antitubercular _xadverse effects |
650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 |
_aBromocriptine _xtherapeutic use |
650 | 0 | 4 |
_aCycloserine _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeuroleptic Malignant Syndrome _xcomplications |
650 | 0 | 4 |
_aPsychoses, Substance-Induced _xcomplications |
700 | 1 | _aKate, Natasha S | |
700 | 1 | _aBhatankar, Swaroop S | |
700 | 1 | _aKulkarni, Prathamesh S | |
773 | 0 |
_tIndian journal of pharmacology _gvol. 47 _gno. 3 _gp. 328-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4103/0253-7613.157134 _zAvailable from publisher's website |
999 |
_c24976964 _d24976964 |